MiNK Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 68.66 K | $802.64 K | 15.66% | 1.37% |
| DNB ASSET MANAGEMENT AS | 08/11/2026 | 55.14 K | $644.61 K | 100.00% | 1.10% |
| LONGBOW FINANCE SA | 07/29/2026 | 16.67 K | $194.84 K | 0.00% | 0.33% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 15.57 K | $182.08 K | -10.22% | 0.31% |
| CITADEL ADVISORS LLC | 09/02/2026 | 15.44 K | $180.49 K | 100.00% | 0.31% |
| BLACKROCK, INC. | 08/07/2026 | 13.38 K | $156.44 K | 115.73% | 0.27% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 8.29 K | $96.88 K | 0.00% | 0.17% |
| UBS GROUP AG | 08/13/2026 | 4.89 K | $57.11 K | -67.87% | 0.10% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 08/13/2026 | 2.00 K | $23.38 K | 0.00% | 0.04% |
| US BANCORP \DE\ | 08/12/2026 | 2.00 K | $23.32 K | 100.00% | 0.04% |
| PALADIN PARTNERS, LLC | 08/07/2026 | 1.00 K | $11.69 K | 0.00% | 0.02% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/14/2026 | 500 | $5.85 K | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 422 | $4.93 K | 170.51% | 0.01% |
| COVESTOR LTD | 08/07/2026 | 119 | $1.00 K | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 08/14/2026 | 117 | $1.37 K | 11,600.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 113 | $1.32 K | 8.65% | 0.00% |
| BARCLAYS PLC | 08/14/2026 | 24 | $281 | 100.00% | 0.00% |
| MERCER GLOBAL ADVISORS INC /ADV | 08/11/2026 | 23 | $269 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/12/2026 | 18 | $210 | 0.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 18 | $210 | 80.00% | 0.00% |
| GAME PLAN FINANCIAL ADVISORS, LLC | 08/07/2026 | 16 | $187 | 0.00% | 0.00% |
| CLEARSTEAD ADVISORS, LLC | 08/06/2026 | 14 | $164 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 13 | $152 | -18.75% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2026 | 9 | $107 | 0.00% | 0.00% |
| KEY FINANCIAL INC | 07/24/2026 | 4 | $47 | 0.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 2 | $23 | 100.00% | 0.00% |
| LIFESTEPS FINANCIAL, INC. | 07/17/2026 | 2 | $23 | 100.00% | 0.00% |
| JONES FINANCIAL COMPANIES LLLP | 08/14/2026 | 1 | $12 | 0.00% | 0.00% |
| CITIGROUP INC | 08/03/2026 | 0 | $0 | -100.00% | 0.00% |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 08/07/2026 | 0 | $0 | -100.00% | 0.00% |
| ANNIS GARDNER WHITING CAPITAL ADVISORS, LLC | 08/10/2026 | 0 | $0 | -100.00% | 0.00% |
MiNK Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 36 institutional investors and hedge funds held shares of MiNK Therapeutics Inc. The most heavily invested institutionals were:
VANGUARD CAPITAL MANAGEMENT LLC: 68,660
DnB Asset Management AS: 55,142
Longbow Finance SA: 16,667
GEODE CAPITAL MANAGEMENT, LLC: 15,573
CITADEL ADVISORS LLC: 15,440
BlackRock, Inc.: 13,382
4.07% of MiNK Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 361.65 K shares in the last 24 months. This purchase volume represents approximately $3.74 M in transactions.